Overview
The fund is passively managed and is distinguished by broad diversification, low tracking errors, and low-cost management.
The investment objective is to replicate the reference index as closely as possible and to minimize performance deviations from the benchmark.
The MSCI Europe ex Switzerland Index captures large and mid cap representation across Developed Markets countries in Europe (excluding Switzerland).
The index covers approximately 85% of the free float-adjusted market capitalization in the European ex Switzerland equity universe.
Benefits
Easy access to a broadly diversified portfolio of European ex Switzerland Equities.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
| Product category |
麻豆社 Equity Funds 麻豆社 Index Funds Equities |
| Product domicile |
Switzerland
|
| Portfolio management |
麻豆社 Asset Management Switzerland AG, Zurich
|
| Fund management |
麻豆社 Fund Management (Switzerland) AG
|
| Custodian bank |
麻豆社 Switzerland AG, Zurich
|
| Day of inception |
September 9, 2016
|
| Currency of account |
CHF
|
| Close of financial year |
February 28
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.19% p.a.
|
| Total expense ratio (TER) |
0.23% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Europe ex Switzerland (NR) in CHF
|
| Securities no. |
33620669
|
| ISIN |
CH0336206690
|
| Bloomberg Ticker |
CSIEUFA SW
|
| Reuters Id |
33620669X.CHE
|
Performance and Prices
Percentage growth
as of May 27, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 5.40 | 7.20 | 6.12 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 18.81 | 19.83 | 35.90 |
| 3Y | |||
| 5Y | 38.82 | 66.23 | 58.40 |
| ø p.a.5Y | 6.78 | 10.70 | 9.64 |
Current data
| Net asset value | 27.05.2026 | CHF 1,736.84 |
| High - last 12 months | 17.04.2026 | CHF 1,742.62 |
| Low - last 12 months | 23.06.2025 | CHF 1,497.51 |
| Assets of the unit class in mn | 27.05.2026 | CHF 6.43 |
| Total product assets in mn | 27.05.2026 | CHF 306.35 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 30.04.2026 | 9.90% | 13.24% |
| Sharpe Ratio | 30.04.2026 | 0.88 | 0.48 |
| Risk Free Rate | 30.04.2026 | 0.40% | 0.41% |
Structures
By the 10 largest positions (in %, as of April 30, 2026)
|
|
|
| 麻豆社 MSCI EMU NSL | 32.91 |
| 麻豆社 Lux Fund Solutions II-麻豆社 MSCI EMU Selection | 12.15 |
| HSBC Holdings PLC | 2.59 |
| AstraZeneca PLC | 2.42 |
| Shell PLC | 2.13 |
| Novo Nordisk A/S | 1.16 |
| Rolls-Royce Holdings PLC | 1.11 |
| British American Tobacco PLC | 1.05 |
| Unilever PLC | 1.05 |
| BP PLC | 1.03 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|
|
Document type
|
Document Language
|
|||
| Tax list |
|
|
|
|